Friday, July 10, 2026

Drug profile · INN

colistimethate

colistimethate is a cell membrane disrupting agent.

NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — colistimethate
Class
Route
Patents
0
Programs
1
Data quality
0.70

Quick answer

colistimethate is a cell membrane disrupting agent.

Key facts

INN colistimethate
Mechanism Cell membrane disrupting agent
Target Cell membrane

Mechanism of action

Cell membrane disrupting agent

Primary target: Cell membrane

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. Pharmacokinetic study of colistimethate sodium Phase 1 · Zaklady FarmaFarmaceutyczne Polpharma · serious infections caused by selected aerobic gram-negative

Related & competitor drugs

  1. colistimethate sodium Antiinfectives for systemic use (J01)
  2. daptomycin Antiinfectives for systemic use (J01)
  3. candicidin Cell membrane inhibitor
  4. chlorhexidine gluconate Cell membrane inhibitor
  5. deoxycholic acid Cell membrane disrupting agent
  6. gramicidin Cell membrane inhibitor

Frequently asked questions

What is colistimethate?

colistimethate is a cell membrane disrupting agent.